GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 116 filers reported holding GW PHARMACEUTICALS PLC in Q4 2015. The put-call ratio across all filers is 2.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $5,094,000 | +9.2% | 116,947 | +21.5% | 7.68% | -4.5% |
Q2 2017 | $4,665,000 | +18.5% | 96,257 | +5.2% | 8.03% | +55.0% |
Q1 2017 | $3,937,000 | +36.4% | 91,529 | -56.6% | 5.18% | +56.3% |
Q4 2016 | $2,887,000 | -47.7% | 210,800 | +0.4% | 3.32% | -24.2% |
Q3 2016 | $5,517,000 | +194.6% | 210,000 | +19.8% | 4.37% | +172.0% |
Q2 2016 | $1,873,000 | +90.9% | 175,300 | +64.0% | 1.61% | +56.6% |
Q1 2016 | $981,000 | -33.9% | 106,900 | +18.6% | 1.03% | -6.2% |
Q4 2015 | $1,484,000 | – | 90,100 | – | 1.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |